{"id":"W2956067738","doi":"10.1158/1538-7445.am2019-ct073","title":"Abstract CT073: Pembrolizumab after two or more lines of prior therapy in patients with advanced small-cell lung cancer (SCLC): Results from the KEYNOTE-028 and KEYNOTE-158 studies","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Oncology; Progression-free survival; Lung cancer; Cancer; Phases of clinical research; Surrogate endpoint; Immunotherapy; Clinical trial; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001591468,0.0006373592,0.001158941,0.0003269394,0.0003671821,0.0009304446,0.0006644714,0.0008079149,0.003854111],"category_scores_gemma":[0.00153258,0.0002176691,0.001457119,0.0006484832,0.0003236314,0.0009304943,0.000495158,0.001687766,0.0007663238],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001175501,"about_ca_system_score_gemma":0.001296404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00180673,"about_ca_topic_score_gemma":0.00473641,"domain_scores_codex":[0.9992502,0.0003279462,0.00007946123,0.0001413273,0.0001122017,0.00008876832],"domain_scores_gemma":[0.9983569,0.0003237484,0.0005280644,0.0001205239,0.0001505579,0.0005201927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7206503,0.007714143,0.1213083,0.001564366,0.004447194,0.0003716566,0.0001733309,0.001470148,0.01549421,0.0001388578,0.008097223,0.1185703],"study_design_scores_gemma":[0.2047156,0.2471558,0.5179743,0.000478251,0.005515621,0.00149938,0.0002434683,0.003068875,0.006802554,0.0002962544,0.01214115,0.0001088255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857032,0.007058947,0.0002399759,0.0004215253,0.00008362473,0.0005208211,0.003492991,0.00005191462,0.002426917],"genre_scores_gemma":[0.9903868,0.001507583,0.000374461,0.0005515639,0.0001228175,0.0003046806,0.005706602,0.00001196695,0.001033551],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003854111,"threshold_uncertainty_score":0.01289332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05775550792935844,"score_gpt":0.4330473040302196,"score_spread":0.3752917961008612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}